These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5871729)

  • 1. Neurochemical correlates of behavior. V. Differential effects of drugs on approach and avoidance behavior in rats with related changes in brain serotonin and norepinephrine.
    Aprison MH; Hingtgen JN
    Recent Adv Biol Psychiatry; 1965; 8():87-100. PubMed ID: 5871729
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical correlates of behaviour. Changes in acetylcholine, norepinephrine and 5-hydroxytryptamine concentrations in several discrete brain areas of the rat during behavioural excitation.
    Aprison MH; Kariya T; Hingtgen JN; Toru M
    J Neurochem; 1968 Oct; 15(10):1131-9. PubMed ID: 5711126
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of brain amines in the behavioral depression produced by a benzoquinolizine.
    Miller FP; Maickel RP
    Life Sci; 1969 May; 8(9):487-91. PubMed ID: 5791701
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical correlates of behavior. Content of tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid, tyrosine, dopamine and norepinephrine in a nerve ending fraction isolated from three brain areas of the pigeon during the period of behavioral depression following an injection of tryptophan.
    Smith JE; Hingtgen JN; McBride WJ; Aprison MH
    J Neurochem; 1976 Sep; 27(3):747-51. PubMed ID: 1085813
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral and neurochemical effects of psychotomimetic drugs in neonate chicks.
    Wallach MB; Friedman E; Gershon S
    Eur J Pharmacol; 1972 Feb; 17(2):259-69. PubMed ID: 5026400
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice.
    Shah NS
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):201-4. PubMed ID: 4686103
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pre- and postnatal cholecystokinin treatment on brain development in rats.
    Telegdy G; Balázs M; Fekete M
    Monogr Neural Sci; 1986; 12():153-60. PubMed ID: 3642223
    [No Abstract]   [Full Text] [Related]  

  • 8. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin and behavior: a brief summary.
    Aprison MH; Hingtgen JN
    Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
    [No Abstract]   [Full Text] [Related]  

  • 10. Some agonistic actions of the morphone antagonist levallorphan on behavior and brain monoamines in the rat.
    Steinert HR; Holtzman SG; Jewett RE
    Psychopharmacologia; 1973 Jul; 31(1):35-48. PubMed ID: 4721474
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain.
    Schildkraut JJ; Efron DH
    Psychopharmacologia; 1971; 20(2):191-6. PubMed ID: 5090538
    [No Abstract]   [Full Text] [Related]  

  • 12. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 13. [The behavioral and neurochemical changes in rats caused by the subchronic administration of haloperidol].
    Shevchenko TP; Tolpyshev BA; Zban' LN
    Eksp Klin Farmakol; 1993; 56(3):15-7. PubMed ID: 8219980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neurochemical effects of lesions in the raphe system of the rat.
    Lorens SA; Sorensen JP; Yunger LM
    J Comp Physiol Psychol; 1971 Oct; 77(1):48-52. PubMed ID: 5120684
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of apomorphine and amphetamine on schedule-controlled behavior: reversal of tetrabenazine suppression and dopaminergic correlates.
    Butcher LL; Andén NE
    Eur J Pharmacol; 1969; 6(3):255-64. PubMed ID: 5799188
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prenylamine on locomotor activity and brain monoamine levels in mice.
    Ahtee L; Kärki N
    Acta Pharmacol Toxicol (Copenh); 1968; 26(1):55-63. PubMed ID: 5694266
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in monoamines of rat brain during postnatal ontogeny.
    Agrawal HC; Glisson SN; Himwich WA
    Biochim Biophys Acta; 1966 Dec; 130(2):511-3. PubMed ID: 5972858
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral reaction of rats pretreated with reserpine to LSD-25.
    Votava Z; Glisson SN; Himwich HE
    Int J Neuropharmacol; 1967 Nov; 6(6):543-7. PubMed ID: 5586670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.